New York Senate Bill 2383: Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

New York · 2025-2026 session

What it does

Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

Latest action

REFERRED TO HEALTH (2026-01-07)

See how S 2383 affects you on CapitolKey

Browse more bills · CapitolKey home